Castle Biosciences IPO raises $73.6 Million

Castle Biosciences is a commercial-stage dermatological cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions.

The company is headquartered in Friendswood, Texas and has Laboratory/Clinical Operations in Phoenix, Arizona.  

 AZBio Member News

Meet MAT

Pharmaceutical Research and Manufacturers of America (PhRMA) created the Medicine Assistance Tool (MAT) to provide a dedicated search engine that allows users to search for financial assistance resources available to them, their loved ones or patients in their lives through the various biopharmaceutical industry programs available for patients who are eligible.

During National Immunization Awareness Month, Arizona Professional Organizations and Citizens Urge Action to Improve Childhood Vaccination Rates

Health Advocates visit the Arizona Capitol to share important messages.

Follow The Pill

Today, much of the public debate surrounding the cost of biopharmaceuticals is focused on the list price of an individual drug or treatment regimen. However, the list price is not what a manufacturer generally makes on the drug, and it typically has little to do with what a patient has to pay for his or her medicine. To help put this debate into context, here is an educational video that helps explain how prescription drug costs are really determined and where the pharmaceutical dollar actually goes.

New study reviews unregulated stem cell clinics in six SW states 

Expertise of providers, legitimacy of therapies examined

Aug. 1, 2019, Tempe, Arizona — Unproven and unregulated stem cell therapies for treatments for conditions ranging from Parkinson’s disease to multiple sclerosis to macular degeneration are putting patients at risk in a market that has grown rapidly in recent years.

UA Researcher and Doctoral Student Reconcile Scientific Standoff in Colon Cancer Research

Curtis Thorne, PhD, and UA doctoral student Carly Cabel validated findings from a 2018 collaborative study that identified a possible new therapeutic target for colon cancer – after a Harvard lab challenged the initial results.

Opportunity Alerts

Graduate Certificate in Regulatory Science 

The University of Arizona James E. Rogers College of Law and the Critical Path Institute (C-Path) have joined together to create a fully online program.

The Rocky Mountain Life Science Investor & Partnering Conference

The sister conference to White Hat, RMLSIPC will be held In Vail, CO on Sept. 4-5, 2019.

RESI 2019 – Boston – Sept. 11, 2019

The RESI Boston Conference includes opportunities for the earliest stage companies from the discovery stage through venture stage: companies seeking grants, seed, angel, series A, and series B funding. 

JOBS

Biotech Marketing Consultant  – NANOPEC – Tucson

Post Doc – Narayanan Lab – TGen – Phoenix

Education and Outreach Specialist – TGen – Phoenix

Eyring Materials Center, TEM/STEM Research Scientist (All Ranks) – Arizona State University – Tempe

Research Associate II – TGen Integrative Cancer Genomics division – Phoenix

BioPharma Business Development Manager – Ashion Analytics, LLC – Phoenix

Director, Translational Cardiovascular Research Center of Excellence (TE/T) Phoenix, AZ) – University of Arizona – Phoenix

Click here to view ALL opportunities or post positions at your  company.  

Internship postings are always FREE

Events  – Committees – Savings

The next AZBio Government Affairs Call will be in AUGUST

Thursday, August  8th at 3 PM  AZ/PDT

All AZBio Members are welcome to join the AZBio Government Affairs Committee.  Click here to be added to the committee